NovaBridge Biosciences (NBP) Interest Coverage Ratio (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Interest Coverage Ratio of 288.14 for Q4 2025, down 408.58% year-on-year from 93.38 in Q4 2024, and down 60721.14% on a QoQ basis from 0.47 in Q3 2025.
NovaBridge Biosciences (NBP) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Interest Coverage Ratio for 5 consecutive years, with 288.14 the latest figure, recorded in Q4 2025.
- Quarterly Interest Coverage Ratio fell 408.58% year-over-year to 288.14 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 131.11 (down 18.81% YoY) and the FY2025 annual result came in at 1.23, down 34.47% from the prior year.
- Interest Coverage Ratio slipped to 288.14 in Q4 2025 per NBP's latest filing, from 0.47 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for NBP reached as high as 0.24 in Q4 2023 and fell as low as 288.14 in Q4 2025.
- A 3-year average of 66.84 and a median of 27.75 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio slumped 23650.78% — and 2025, when it surged 99.12%.
- Year by year, Interest Coverage Ratio stood at 0.24 in 2023, then sank by 23650.78% to 56.66 in 2024, then plunged by 408.58% to 288.14 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 288.14, 0.47, and 1.54 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -288.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -288.14 |
| Sep 30, 2025 | -0.47 |
| Jun 30, 2025 | -1.54 |
| Dec 31, 2024 | -56.66 |
| Sep 30, 2024 | -53.97 |
| Dec 31, 2023 | -0.24 |
| Dec 31, 2020 | 854.96 |
| Sep 30, 2020 | 504.15 |
| Dec 31, 2019 | 47.72 |
| Sep 30, 2019 | -25.70 |